EDGAR·FLOW

Silexion Therapeutics Corp — Form 8-K

Filed November 19, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 8/100
What the filing says
Silexion Therapeutics filed an 8-K on 2026-11-19 disclosing Item 8.01 (Other Events) with no material details provided in the accessible text. No counterparties, dollar amounts, dates, or business developments are specified in the filing extract. The document contains only XBRL formatting files and boilerplate SEC header information.
Why this rating

No substantive event disclosed; pure administrative filing. Routine periodic disclosure unrelated to company operations or financial condition.

Extracted items
View original filing on SEC.gov ↗ SLXNW · stock on Yahoo Finance ↗

See more from November 19, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.